Saltar al contenido
Merck
  • Cyanuric chloride catalyzed mild protocol for synthesis of biologically active dihydro/spiro quinazolinones and quinazolinone-glycoconjugates.

Cyanuric chloride catalyzed mild protocol for synthesis of biologically active dihydro/spiro quinazolinones and quinazolinone-glycoconjugates.

The Journal of organic chemistry (2011-12-21)
Moni Sharma, Shashi Pandey, Kuldeep Chauhan, Deepty Sharma, Brijesh Kumar, Prem M S Chauhan
RESUMEN

We have developed an efficient cyanuric chloride (2,4,6-trichloro-1,3,5-triazine, TCT) catalyzed approach for the synthesis of 2,3-dihydroquinazolin-4(1H)-one (3a-3x), 2-spiroquinazolinone (5, 7), and glycoconjugates of 2,3-dihydroquinazolin-4(1H)-one (10a, 10b) derivatives. The reaction allows rapid cyclization (8-20 min) with 10 mol % cyanuric chloride to give skeletal complexity in good to excellent yield. We believe that this novel procedure may open the door for the easy generation of new and bioactive quinazolinones.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Cyanuric chloride, 99%
Sigma-Aldrich
Anthranilamide, ≥98%